How To Get Involved
PARTNER WITH US
It's never too early to get involved! Based on your objectives, we can create bespoke packages designed specifically for you.
From presenting your expertize on the main stage to hosting the infamous Drinks Reception. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
Discuss your objectives with Jack Tollervey, Commercial Partnerships Manager; [email protected]
REGISTER AS A DELEGATE
Step into interactive discussions and engaging presentations on the key challenges and opportunities presented.
Register your interest and be the first to hear updates on the 2024 Congress.
Why Attend
The field of multi-specifics has accelerated, and substantial interest is owed to its flexibility, modularity, specificity and promise to be the ultimate set of modalities for precision oncology and beyond. As the field patiently waits for clinical trial readouts to feed into and optimise the overwhelming amount of preclinical candidates in the space, some say we are entering the next era and well into the 4th wave of drug discovery, beyond current targets and disease indications. Ongoing research efforts in academia and industry prepare us for the next wave of challenges that need to be overcome:
- Exploring novel biology, target and pathway selection for current and novel formats geared towards optimizing cancer targets and novel indications
- Innovative design and engineering challenges, developing assays that explore innovative format architecture in a rational way, away from long bouts of archaic trial and error and well into modelling and prediction
- Improving safety and efficacy profiles of current and emerging candidates
- Improving immune response modulation: to support the performance of multispecific drugs, exploring ways to tune/steer the immune response or induce synthetic immunity to mimic endogenous immune response, and study and prevent resistance mechanisms
2023 Speakers
Wei Xu
Alexander Schinagl
Colette Johnston
Jonathan Davis
Laura Von Schantz
Anne Goubier
Stefan Zielonka
Anders Carlsson
Peter Lowe
Simone de Haij
Pauline Van Helden
Stephen Harper
Qian Zhang
Claudio Sustmann
Roberto De Luca
David Eisen
Regis Cebe
Jeanette Leusen
Harold Kolmar
Mark Chiu
Stuart Barnscher
Marie-Cecile van de Lavoir, DVM, PhD
The Agenda
The European Bispecific & Multispecific Antibody Congress 2023 agenda is here! Simply fill out the short form and access your copy immediately.
Key content covers:
- Improving the efficacy and quality of bispecific antibodies through exploration of the best design
- Optimising and future proofing the multispecifics landscape by analysing format and design trends within the clinic
- Analysing trends in format and design that have shown success in the clinic and how to inform and optimise future candidates
- De-risking multispecific development pipelines through the integration of analytics in early format design and engineering
- Implementing more innovative strategies for developing multispecific NK cell engagers
DOWNLOAD THE 2023 AGENDA
2023 Partners
Platinum Partners
ATUM
Website: https://www.atum.bio
ProteinGPS is an engineering technology that can modify proteins for real world applications. A small number of variants are tested using high quality assays representative of the functionality, developability and manufacturability properties that your protein will need. Iterative machine learning and testing steps result in an engineered protein that will work where it matters: the real world.
Bionamic
Website: https://www.bionamic.io
Bionamic is a company in Lund, Sweden, founded by Anders Carlsson, Ph.D. and Morten Krogh, Ph.D. with the combined experiences from life science (Scripps Research and USC), theoretical physics (Princeton and CERN) and software development. The idea behind Bionamic was developed while consulting at various biopharma companies, where the challenges of organizing and analyzing development data were obvious and researchers were frustrated by the inefficiencies caused by the lack of appropriate software. It is Bionamic’s mission to change this by providing a software platform developed around the biopharma discovery and development process, soundly built on true biological concepts and relations. The main purpose of the Bionamic system is to allow users to act on their data in the easiest and most efficient way possible.
OmniAb
Website: https://www.omniab.com/
OmniAb, Inc.’s discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics. At the heart of the OmniAb platform is the Biological Intelligence™ (BI) of our proprietary transgenic animals, including OmniRat®, OmniChicken® and OmniMouse® that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. OmniFlic® (transgenic rat) and OmniClic® (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur™ features unique structural attributes of cow antibodies for complex targets.
Silver Partner
Event Partner
Absolute Biotech
Website: https://www.absolutebiotech.com
Absolute Biotech unites multiple antibody-centric brands into a single organization specializing in antibody reagents, kits and services. We offer a wide selection of catalog reagents, as well as custom antibody sequencing, engineering and recombinant expression services. Our mission is to serve as “antibody curators” for customers worldwide, treating each antibody like a work of art to deliver unique and absolutely defined reagents that empower scientists.
Absolute Biotech offers antibody sequencing from hybridomas or purified protein, and recombinantly produces antibodies at milligram-to-gram scale in our transient expression system at our ISO-certified manufacturing facility. Our engineering services include species, isotype and subtype switching; chimerization and humanization; and developing antibody fragments, Fc fusion proteins, and multispecific (bispecific and trispecific) antibodies. To date, we have engineered and manufactured more than 180 antibody formats using our proprietary cloning system, which enables rapid reformatting of antibodies into almost any format.
Become a partner
Kisaco Research provides the platform where industry executives can network, learn and meet potential industry partners.
Far from the typical ‘meet-and-greet’ experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand.
Your partnership with Kisaco Research will offer you a strategic approach that is an extension and enhancement of your own marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets.
Find out more by calling us at +44 (0)20 3696 2920 or email Jack Tollervey at [email protected]
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.